Author By adminPosted on February 23, 2025February 23, 2025 The U.S. FDA Grants Fast Track Designation to Coherent Biopharma’s CBP-1019 Suzhou, China, February 21, 2025 — Coherent Biopharma (“Coherent”) announced that the U.S. Food and Drug Administration...
Author By adminPosted on October 12, 2024October 12, 2024 The U.S. FDA Grants Fast Track Designation to Coherent Biopharma’s CBP-1008 October 10, 2024 — Coherent Biopharma (“Coherent”) announced that the U.S. Food and Drug Administration (FDA) has grant...
